As indicated in the letter, Nasdaq determined that for 10 consecutive business days, the closing bid price of the Company’s common stock was at or above
About
Investors:
Director of IR
Jason@180lifesciences.com
![](https://ml.globenewswire.com/media/MmFiNGZmOGYtNTQyZS00MGNkLTllNjUtZjg0NDRiNjVjNTVhLTEyMTUyNTY=/tiny/180-Life-Sciences-Corp-.png)
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | -7.79% |
|
+36.54% | -47.49% |
May. 15 | 180 Life Sciences Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | 180 Life Sciences Corp. Announces Management Changes | CI |
As indicated in the letter, Nasdaq determined that for 10 consecutive business days, the closing bid price of the Company’s common stock was at or above
About
Investors:
Director of IR
Jason@180lifesciences.com
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-47.49% | 2.01M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |